New Hampshire Oncology-Hematology, PA

Hooksett, New Hampshire 03106

0 studies enrolling now · 10 studies all time

What they study most

Blood Clot, Breast Cancer, Cancer, DCIS, Deep Vein Thrombosis (DVT), Ductal Carcinoma in Situ, Hormone Refractory Prostate Cancer, Metastatic Colorectal Cancer, Pancreatic Cancer, Prostate Cancer, Pulmonary Embolism (PE), Venous Thromboembolism

Studies at this site

• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS — Running, not enrolling
• T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) — Completed
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer — Completed
• Study of Vitamin D in Untreated Metastatic Colorectal Cancer — Completed
• Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer — Completed
• Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer — Completed
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed
• Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed